Synovial sarcomas (SS) represent a unique subset of soft tissue sarcomas (STS) and
account for 5–10% of all STS. Synovial sarcoma differs from other STS by the relatively …

Synovial sarcoma (SS) is a malignant mesenchymal neoplasm with variable epithelial
differentiation, with a propensity to occur in young adults and which can arise at almost any …

Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Context.—Histologic grading is the most important prognostic factor and the best indicator of
metastatic risk in adult soft tissue sarcomas. The most commonly used systems are the …

Synovial sarcoma (SS) is a rare sarcoma driven by a translocation between SS18 and SSX
1, 2, or 4. With approximately 800 to 1,000 cases a year in the United States, it most …

BACKGROUND: Synovial sarcoma (SS) is a typical soft tissue sarcoma subtype crosswise
between the pediatric and the adult age groups. Less satisfactory overall outcome has been …

Synovial sarcoma is the fourth most common type of soft-tissue sarcoma, accounting for
2.5%–10.5% of all primary soft-tissue malignancies worldwide. Synovial sarcoma most often …

Background Synovial sarcoma (SS) is a malignant soft tissue sarcoma with a poor prognosis
because of late local recurrence and distant metastases. To our knowledge, no studies have …

Synovial sarcoma accounts about 9% of soft tissue sarcomas, most commonly develops in
the extremity of young adults, is considered high grade and contains a characteristic …

The paper report the results of the first European prospective nonrandomized trial dedicated
to pediatric synovial sarcoma. The study included 138 patients treated from 2005 to 2012 …